Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT2BR/β-arrestin2 pathway
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Background: Fluoxetine, a selective serotonin reuptake inhibitor, has been reported to directly bind with 5-HT 2B receptor (5-HT 2B R), but the precise mechanisms, whereby fluoxetine confers the anti-depressive actions via 5-HT 2B R is not fully understood. Although neuroinflammation-induced A1 astrocytes are involved in neurodegenerative diseases, the role of A1 astrocyte in the pathogenesis and treatment of major depressive disorder (MDD) remains unclear. Methods: Mice were subjected to chronic mild stress (CMS) for 6 weeks and subsequently treated with fluoxetine for 4 weeks. The depressive-like and anxiety-like behaviors and the activation of A1 reactive astrocyte in hippocampus and cortex of mice were measured. Primary astrocytes were stimulated with A1 cocktail (tumor necrosis factor (TNF)-α, interleukin (IL)-1α and C1q), activated (LPS) microglia-conditioned medium (MCM) or IL-6 for 24 h and the expression of A1-special and A2-special markers were determined using RT-qPCR and western blot. The role of 5-HT 2B R in the effects of fluoxetine on A1 reactive astrocyte was measured using 5-HT 2B R inhibitor and siRNA in vitro and AAVs in vivo. The functions of downstream signaling Gq protein and β-arrestins in the effects of fluoxetine on the activation of A1 astrocyte were determined using pharmacological inhibitor and genetic knockout, respectively. Results: In this study, we found that fluoxetine inhibited the activation of A1 reactive astrocyte and reduced the abnormal behaviors in CMS mice, as well as ameliorated A1 astrocyte reactivity under three different stimulators in primary astrocytes. We also showed that astrocytic 5-HT 2B R was required in the inhibitory effects of fluoxetine on A1 reactive astrocyte in MDD in vivo and in vitro. We further found that the functions of fluoxetine in the activation of A1 astrocyte were independent of either Gq protein or β-arrestin1 in vitro. β-arrestin2 pathway was the downstream signaling of astrocytic 5-HT 2B R mediated the inhibitory effects of fluoxetine on A1 astrocyte reactivity in primary astrocytes and CMS mice, as well as the improved roles of fluoxetine in behavioral impairments of CMS mice. Conclusions: These data demonstrate that fluoxetine restricts reactive A1 astrocyte via astrocytic 5-HT 2B R/β-arrestin2 pathway in a mouse model of MDD and provide a novel therapeutic avenue for MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, long-term treatment with fluoxetine, a typical SSRIs, reverses the stress-induced reduction in the quantity of astrocytic cells in the hippocampus in a tree shrew model of depression. 55”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [55]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Fluoxetine has been reported to suppress the activation of A1 reactive astrocytes and decrease unusual behaviors in CMS-exposed mice.”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“In vitro, Gq protein and b-arrestin1 are not necessary for fluoxetine’s effects on A1 astrocyte activation, and downstream signaling through astrocytic 5-HT 2B R is responsible for fluoxetine’s inhibitory effects on A1 astrocyte activation in primary culture. 55”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“Both in vivo and in vitro, fluoxetine’s inhibitory actions on A1 reactive astrocytes depend on astrocytic 5-HT 2B R. 55”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 68 · Cited by 96
Metadata
- Authors
- Fang, Y., Ding, X., Zhang, Y., Cai, L., Ge, Y., Ma, K., Xu, R., Li, S., Song, M., Zhu, H., Liu, J., Ding, J., Lu, M., & Hu, G.
- Affiliations
- Nanjing Medical University (CN)
- Nanjing University of Chinese Medicine (CN)
- Corresponding author
- Hu, Gang
- Venue
- Journal of Neuroinflammation
- Published
- 2022-01-29
- Volume
- 19
- Issue
- 1
- Pages
- 23-23
- ISSN
- 1742-2094 (ISSN-L)
- PMC
- PMC8800238
- OpenAlex
- W4210544342
- Cited by
- 96
- References
- 68
- Citations by year
- 2026: 19 · 2025: 34 · 2024: 20 · 2023: 14 · 2022: 9
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Neuroinflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (81630099, 81991523, 81703488)
- Drug Innovation Major Project (2018ZX09711001-003-007)
- Natural Science Foundation of the Basic Research Program of Jiangsu Province (BK20171061)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- fluoxetine, major depressive disorder, 5-HT2B receptor, β-arrestin2, chronic mild stress, neuroinflammation, Gq protein, hippocampus, astrocyte activation, anxiety-like behavior, depression-like behavior, interleukin-6, TNF-α, C1q
- MeSH terms
- beta-Arrestin 2, Animals, Astrocytes, Major Depressive Disorder, Fluoxetine, Serotonin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT2BR/β-arrestin2 pathway. https://app.cochat.ai/papers/10.1186/s12974-022-02389-y
- The paper
- Fang, Y., Ding, X., Zhang, Y., Cai, L., Ge, Y., Ma, K., Xu, R., Li, S., Song, M., Zhu, H., Liu, J., Ding, J., Lu, M., & Hu, G. (2022). Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT2BR/β-arrestin2 pathway. Journal of Neuroinflammation. https://doi.org/10.1186/s12974-022-02389-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.